GLOBEIMMUNE INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GBIM and buy or sell other stocks, ETFs, and their options commission-free!About GBIM
GlobeImmune, Inc. is a biopharmaceutical company. It engages in the development of therapeutic products for cancer and infectious diseases based on its proprietary Tarmogen platform.
CEOTimothy C. Rodell, Jr., MD
CEOTimothy C. Rodell, Jr., MD
Employees3
Employees3
HeadquartersLouisville, Colorado
HeadquartersLouisville, Colorado
Founded1995
Founded1995
Employees3
Employees3
GBIM Key Statistics
Market cap575.20
Market cap575.20
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume30.00
Average volume30.00
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0401
52 Week high$0.0401
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
GLOBEIMMUNE INC Common Stock(GBIM) stock is priced at $0.00, giving the company a market capitalization of 575.2.
On 2026-10-29, GLOBEIMMUNE INC Common Stock(GBIM) stock opened at —, reached a high of —, and a low of —.
GLOBEIMMUNE INC Common Stock(GBIM) shares are trading with a volume of 0, against a daily average of 30.
In the last year, GLOBEIMMUNE INC Common Stock(GBIM) shares hit a 52-week high of $0.04 and a 52-week low of $0.00.
In the last year, GLOBEIMMUNE INC Common Stock(GBIM) shares hit a 52-week high of $0.04 and a 52-week low of $0.00.